Casirivimab + Imdevimab

Casirivimab + Imdevimab is a combination of two monoclonal antibodies used in the treatment and prevention of COVID-19. It is especially helpful in people with mild to moderate symptoms who are at high risk of progressing to severe disease. This combination therapy helps the immune system fight the virus and reduce the risk of hospitalization. Administered under medical supervision, this treatment gained emergency use authorization during the pandemic for its effective antiviral action.

Uses of Casirivimab + Imdevimab

• Treatment of mild to moderate COVID-19 in high-risk patients
• Prevention of COVID-19 in people exposed to the virus
• Reduces the risk of severe infection and hospitalization
• Supports early viral clearance in COVID-19 patients

How Casirivimab + Imdevimab works

Casirivimab and Imdevimab are laboratory-made antibodies that bind to the spike protein of the coronavirus. This prevents the virus from entering human cells and helps the immune system neutralize the virus more effectively. This action limits the infection and reduces severity.

Benefits of Casirivimab + Imdevimab

• Reduces viral load quickly
• Helps in faster recovery from COVID-19
• Lowers chances of hospitalization
• Effective for patients with weak immune systems
• May prevent infection in high-risk exposure cases

How to take Casirivimab + Imdevimab

This medication is given through intravenous (IV) infusion or subcutaneous injection under the supervision of a trained healthcare provider. Dosage is determined by the patient's condition and doctor’s recommendation. It should not be self-administered or taken without a prescription.

Type of Dosage Available

• Casirivimab 600 mg + Imdevimab 600 mg injection
• Casirivimab 1200 mg + Imdevimab 1200 mg injection

Side effects of Casirivimab + Imdevimab

• Injection site reactions (pain, redness, swelling)
• Nausea
• Fever
• Chills
• Headache
• Dizziness
• Shortness of breath (rare but serious)
• Allergic reactions (rare)

Safety advice

• Should only be used under medical supervision
• Not recommended for patients already hospitalized for COVID-19
• Inform doctor about allergies or medical history
• Monitor for signs of allergic reactions post-injection
• Pregnant or breastfeeding women should consult a doctor before use

Frequently Asked Questions (FAQs)

Q. What is Casirivimab + Imdevimab used for?
A. It is used to treat and prevent COVID-19 in people at high risk of severe disease.

Q. How is Casirivimab + Imdevimab given?
A. It is given by injection or infusion in a hospital or clinic by a healthcare provider.

Q. Is this medicine safe for pregnant women?
A. Pregnant women should use it only if clearly needed and prescribed by a doctor.

Q. Can I take this medicine at home?
A. No, it must be administered in a clinical setting under medical supervision.

Q. What should I do if I experience side effects?
A. Contact your doctor immediately, especially if you notice breathing issues or allergic reactions.